Abstract:BACKGROUND:Growing evidence shows that pancreatic tumors in different anatomical locations have different characteristics, which have a significant impact on prognosis. However, no study has reported the differences between pancreatic mucinous adenocarcinoma (PMAC) in the head vs the body/tail of the pancreas.AIM:To investigate the differences in survival and clinicopathological characteristics between PMAC in the head and body/tail of pancreas.METHODS:A total of 2058 PMAC patients from the Surveillance, Epidemiology, and End Results database diagnosed between 1992 and 2017 were retrospectively reviewed. We divided the patients who met the inclusion criteria into pancreatic head group (PHG) and pancreatic body/tail group (PBTG). The relationship between two groups and risk of invasive factors was identified using logistic regression analysis. Kaplan-Meier analysis and Cox regression analysis were conducted to compare the overall survival (OS) and cancer-specific survival (CSS) of two patient groups.RESULTS:In total, 271 PMAC patients were included in the study. The 1-year, 3-year, and 5-year OS rates of these patients were 51.6%, 23.5%, and 13.6%, respectively. The 1-year, 3-year, and 5-year CSS rates were 53.2%, 26.2%, and 17.4%, respectively. The median OS of PHG patients was longer than that of PBTG patients (18 vs 7.5 mo, P < 0.001). Compared to PHG patients, PBTG patients had a greater risk of metastases [odds ratio (OR) = 2.747, 95% confidence interval (CI): 1.628-4.636, P < 0.001] and higher staging (OR = 3.204, 95% CI: 1.895-5.415, P < 0.001). Survival analysis revealed that age < 65 years, male sex, low grade (G1-G2), low stage, systemic therapy, and PMAC located at the pancreatic head led to longer OS and CSS (all P < 0.05). The location of PMAC was an independent prognostic factor for CSS [hazard ratio (HR) = 0.7, 95%CI: 0.52-0.94, P = 0.017]. Further analysis demonstrated that OS and CSS of PHG were significantly better than PBTG in advanced stage (stage III-IV).CONCLUSION:Compared to the pancreatic body/tail, PMAC located in the pancreatic head has better survival and favorable clinicopathological characteristics.

Comparison of the Mutation Profile Between Pancreatic Head/neck and Body/tail Cancers.

Comparative genomic analysis of head and body/tail of pancreatic ductal adenocarcinoma at early and late stages

Comparative Genomic Analysis of Head and Body/tail of Pancreatic Ductal Adenocarcinoma at Early and Late Stages.

Comparative Bioinformatical Analysis of Pancreatic Head Cancer and Pancreatic Body/Tail Cancer

Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes

Whole Exome Sequencing Of Ulcerative Colitis-Associated Colorectal Cancer Based On Novel Somatic Mutations Identified In Chinese Patients

Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing

Comparative analysis of the mutational landscape and evolutionary patterns of pancreatic ductal adenocarcinoma metastases in the liver or peritoneum

Comprehensive Bioinformatical Analysis Identifies Heterogeneity of Genomics and Tumor Microenvironment Between Pancreatic Adenosquamous Carcinoma and Pancreatic Ductal Adenocarcinoma

Comparative Mutational Analysis of Distal Colon Cancer with Rectal Cancer.

Dissimilar Survival and Clinicopathological Characteristics of Mucinous Adenocarcinoma Located in Pancreatic Head and Body/tail.

Mutation Profiling Of Cancer And Stromal Cells From Patients With Pancreatic Ductal Adenocarcinoma.

Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer

A comparison of colon and rectal somatic DNA alterations

Single-Cell Analysis Differentiates the Effects of p53 Mutation and p53 Loss on Cell Compositions of Oncogenic Kras-Driven Pancreatic Cancer

Pancreatic Cancer Genomes Reveal Aberrations in Axon Guidance Pathway Genes

Somatic Mutation Profiles Revealed by Next Generation Sequencing (NGS) in 39 Chinese Hepatocellular Carcinoma Patients

Gene Mutation Profiling in Chinese Colorectal Cancer Patients and Its Association with Clinicopathological Characteristics and Prognosis

Microbiota and metabolite alterations in pancreatic head and body/tail cancer patients

Comparative Mutational Analysis of Biliary Tract Cancers.

Comparing clinical and genomic features based on the tumor location in patients with resected pancreatic cancer